Intestinal type and endocervical-like ovarian mucinous neoplasms are immunophenotypically distinct entities

Applied Immunohistochemistry and Molecular Morphology

Volumn 16, Issue 5, 2008, Pages 453-458

  Lin, Xiaoqi ^a   Lindner, Jennifer L ^b   Silverman, Jan F ^b   Liu, Yulin ^b  

^a NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^b ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

Colorectal adenocarcinoma; Immunohistochemical markers; Intestinal type and endocervical like ovarian mucinous neoplasm

Indexed keywords

CA 125 ANTIGEN; CYTOKERATIN 20; CYTOKERATIN 7; MONOCLONAL ANTIBODY D2-40; THYROID TRANSCRIPTION FACTOR 1; TRANSCRIPTION FACTOR CDX2; TRANSCRIPTION FACTOR PDX 1; TRANSCRIPTION FACTOR; TUMOR MARKER;

ARTICLE; COLORECTAL ADENOMA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; METASTASIS; MUCINOUS CARCINOMA; OVARIAN MUCINOUS NEOPLASM; OVARY METASTASIS; PERITONEAL CAVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERINE CERVIX CARCINOMA; BIOSYNTHESIS; CLASSIFICATION; COLLOID CARCINOMA; COLORECTAL TUMOR; COMPARATIVE STUDY; GENETICS; IMMUNOLOGY; INTESTINE TUMOR; METABOLISM; OVARY TUMOR; PATHOLOGY; RETROSPECTIVE STUDY; UTERINE CERVIX TUMOR;

ADENOCARCINOMA, MUCINOUS; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOPHENOTYPING; INTESTINAL NEOPLASMS; OVARIAN NEOPLASMS; RETROSPECTIVE STUDIES; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 55949134655     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e3181672574     Document Type: Article

References (30)

1. Quirk JT, Natarajan N. Ovarian cancer incidence in the United States, 1992-1999. Gynecol Oncol. 2005;97:519-523.
2. Lee K, Tavassoli F, Prat J, et al. Surface epithelial-stromal tumors. In: Tavassoli FA, Devilee P, eds. Pathology and Genetics: Tumors of the Breast and Female Genital Organs. Lyon, France: IARC Press; 2003:124-129.
3. Hart WR. Mucinous tumors of the ovary: a review. Int J Gynecol Pathol. 2005;24:4-25.
4. Lee KR, Scully RE. Mucinous tumors of the ovary: a clinicopathologic study of 196 borderline tumors (of intestinal type) and carcinomas, including an evaluation of 11 cases with "pseudomyxoma peritonei." Am J Surg Pathol. 2000;24:1447-1464.
5. Hart WR, Norris HJ. Borderline and malignant mucinous tumors of the ovary. Histologic criteria and clinical behavior. Cancer. 1973;31: 1031-1045.
6. Rutgers JL, Scully RE. Ovarian mullerian mucinous papillary cystadenomas of borderline malignancy. A clinicopathologic analysis. Cancer. 1988;61:340-348.
7. Rutgers JL, Scully RE. Ovarian mixed-epithelial papillary cystadenomas of borderline malignancy of mullerian type. A clinicopathologic analysis. Cancer. 1988;61:546-554.
8. Rodriguez IM, Irving JA, Prat J. Endocervical-like mucinous borderline tumors of the ovary: a clinicopathologic analysis of 31 cases. Am J Surg Pathol. 2004;28:1311-1318. (Pubitemid 39336369)
9. Nomura K, Aizawa S. Clinicopathologic and mucin histochemical analyses of 90 cases of ovarian mucinous borderline tumors of intestinal and mullerian types. Pathol Int. 1996;46:575-580. (Pubitemid 126125145)
10. Moriya T, Mikami Y, Sakamoto K, et al. Endocervical-like mucinous borderline tumors of the ovary: clinicopathological features and electron microscopic findings. Med Electron Microsc. 2003;36:240-246. (Pubitemid 38133230)
11. Rodriguez IM, Prat J. Mucinous tumors of the ovary: a clinicopathologic analysis of 75 borderline tumors (of intestinal type) and carcinomas. Am J Surg Pathol. 2002;26:139-152. (Pubitemid 34127494)
12. Hoerl HD, Hart WR. Primary ovarian mucinous cystadenocarcinomas: a clinicopathologic study of 49 cases with long-term followup. Am J Surg Pathol. 1998;22:1449-1462.
13. Riopel MA, Ronnett BM, Kurman RJ. Evaluation of diagnostic criteria and behavior of ovarian intestinal-type mucinous tumors: atypical proliferative (borderline) tumors and intraepithelial, microinvasive, invasive, and metastatic carcinomas. Am J Surg Pathol. 1999;23:617-635.
14. Offield MF, Jetton TL, Labosky PA, et al. PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development. 1996;122:983-995.
15. Hui H, Perfetti R. Pancreas duodenum homeobox-1 regulates pancreas development during embryogenesis and islet cell function in adulthood. Eur J Endocrinol. 2002;146:129-141. (Pubitemid 34162905)
16. Ashizawa S, Brunicardi FC, Wang XP. PDX-1 and the pancreas. Pancreas. 2004;28:109-120.
17. Ritz-Laser B, Gauthier BR, Estreicher A, et al. Ectopic expression of the beta-cell specific transcription factor Pdx1 inhibits glucagon gene transcription. Diabetologia. 2003;46:810-821. (Pubitemid 36831410)
18. Melloul D. Transcription factors in islet development and physiology: role of PDX-1 in beta-cell function. Ann N Y Acad Sci. 2004; 1014:28-37. (Pubitemid 38594788)
19. Lin X, Deng C, Tung M, et al. Diagnostic value of transcriptional factors and differential cytokeratins in separating primary pulmonary from metastatic mucinous cystadenocarcinoma. Mod Pathol. 2005;18(suppl 1):315A.
20. Werling RW, Yaziji H, Bacchi CE, et al. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas. Am J Surg Pathol. 2003;27:303-310. (Pubitemid 36245795)
21. Kim MJ. The usefulness of CDX-2 for differentiating primary and metastatic ovarian carcinoma: an immunohistochemical study using a tissue microarray. J Korean Med Sci. 2005;20:643-648.
22. Kaimaktchiev V, Terracciano L, Tornillo L, et al. The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas. Mod Pathol. 2004;17: 1392-1399. (Pubitemid 39472995)
23. Logani S, Oliva E, Arnell PM, et al. Use of novel immunohistochemical markers expressed in colonic adenocarcinoma to distinguish primary ovarian tumors from metastatic colorectal carcinoma. Mod Pathol. 2005;18:19-25. (Pubitemid 40128090)
24. Vang R, Gown AM, Barry TS, et al. Ovarian atypical proliferative (borderline) mucinous tumors: gastrointestinal and seromucinous (endocervical-like) types are immunophenotypically distinctive. Int J Gynecol Pathol. 2006;25:83-89. (Pubitemid 44638341)
25. Oliva E, Amin MB, Jimenez R, et al. Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems. Am J Surg Pathol. 2002;26:190-197. (Pubitemid 34127498)
26. Loy TS, Quesenberry JT, Sharp SC. Distribution of CA 125 in adenocarcinomas. An immunohistochemical study of 481 cases. Am J Clin Pathol. 1992;98:175-179.
27. O'Neill CJ, Deavers MT, Malpica A, et al. An immunohistochemical comparison between low-grade and high-grade ovarian serous carcinomas: significantly higher expression of p53, MIB1, BCL2, HER-2/neu, and C-KIT in high-grade neoplasms. Am J Surg Pathol. 2005;29:1034-1041. (Pubitemid 41045547)
28. Cathro HP, Stoler MH. Expression of cytokeratins 7 and 20 in ovarian neoplasia. Am J Clin Pathol. 2002;117:944-951.
29. Park SY, Kim HS, Hong EK, et al. Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary. Hum Pathol. 2002;33:1078-1085.
30. Castrillon DH, Lee KR, Nucci MR. Distinction between endometrial and endocervical adenocarcinoma: an immunohistochemical study. Int J Gynecol Pathol. 2002;21:4-10. (Pubitemid 34008346)